Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

REVENUES (Details Narrative)

REVENUES (Details Narrative) - Gross-to-net Sales Allowance [Member] $ in Millions	Sep. 30, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Gross-to-net allowances	$ 2.5
Accounts Receivable [Member]
Disaggregation of Revenue [Line Items]
Gross-to-net allowances	0.7
Accrued Liabilities [Member]
Disaggregation of Revenue [Line Items]
Gross-to-net allowances	$ 1.8

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details